NDC11 63323032112
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0321-12 | 63323-0321 |
| 63323-321-12 | 63323-321 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 704a41f5-b109-4c16-8d3e-1495c9917952 | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | 63323-321-12 63323-321 63323032112 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | fbc12c18-567b-41bc-89d0-efd29616615c | 2021-02-28 | Boxed warning, Warnings, Adverse reactions | 63323-321 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.